20 (AIDX) Assets (2024 - 2026)

20 (AIDX) reported Assets of $5.8 million for Q1 2026, up 40.27% quarter-over-quarter from $4.1 million in Q4 2025.

20 (AIDX) Assets (2024 - 2026) Analysis & Trends

20 has reported Assets for 3 years, with the latest figure at $5.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Assets changed N/A year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (changed N/A YoY), and the FY2025 full-year result was $4.1 million, up 15.43% from the prior year.
  • Assets for Q1 2026 stood at $5.8 million, up from $4.1 million in the prior quarter.
  • The five-year high for Assets was $5.8 million in Q1 2026, with the low at $3.6 million in Q4 2024.
  • Historically, Assets has averaged $4.5 million across 3 years, with a median of $4.1 million in 2025.
  • The largest YoY upside for Assets was 15.43% in 2025 against a maximum downside of 15.43% in 2025.
  • 20's Assets stood at $3.6 million in 2024, then advanced by 15.43% to $4.1 million in 2025, then soared by 40.27% to $5.8 million in 2026.
  • The last three Assets figures came in at $5.8 million (Q1 2026), $4.1 million (Q4 2025), and $3.6 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 20 - - 62,884.00 5.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.80 Mn
Dec 31, 2025 4.14 Mn
Dec 31, 2024 3.58 Mn